Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review
- 49 Downloads
The molecular profile of juvenile nasopharyngeal angiofibroma (JNA) is extremely variable. In absence of established molecular signature the molecular targeting seems difficult for this heterogeneous disease. To establish a basic molecular signature, this paper analyses the interaction of 7 markers according to their ranks as per the decreasing scale of molecular expression.
Materials and methods
Fourteen samples of JNA were obtained following surgical excision and mRNA expressions were established through real-time polymerase chain reaction (RT-PCR) for vasculoendothelial growth factor (VEGF), fibroblastic growth factor (FGF), c-Kit, c-myc, Ras, platelet-derived growth factor (PDGF) and tumor suppressor gene p53. Nasal polyp was taken as control. The quantitative expressions for every marker were ranked on a decreasing scale and were compared by Spearman’s rank correlation test to define the statistically significant interaction. An attempt was also made to overview the basic clinical parameters (age, duration of symptoms, radiological staging, intraoperative haemorrhage and tumor-volume/weight) associated with enhanced molecular expressions for every marker. Results: Five significant molecular interactions were identified on the basis of rank-correlation: (1) FGF/VEGF (p < 0.01); (2) Ras/FGF (p < 0.01); (3) Ras/VEGF (p < 0.001), (4) FGF/c-Kit (p < 0.05); (5) c-Myc/p53 (p < 0.05). These basic ‘molecular signatures’ suggested a preliminary ‘molecular classification’. The implication of the interactions between FGF, VEGF and Ras were the most outstanding observation that not only revealed a direct relationship but were also consistent with the clinical behaviour. In addition, a non-significant interaction was identified with c-Myc/PDGF and also an inverse relationship between FGF/c-Kit.
FGF, VEGF, and Ras being significantly interrelated seemed to be the ‘most soft’ molecular targets for JNA. The other targets observed included FGF/c-Kit and c-Myc/p53 interactions that seemed equally important but only after VEGF/FGF/Ras complex per se. These preliminary signatures are likely to provide a background for further expansion of the molecular classification of JNA.
KeywordsJuvenile nasopharyngeal angiofibroma Molecular interactions VEGF FGF C-Kit c-Myc Ras PDGF P53
The principal author would like to acknowledge Dr. Girija Kant Shukla Professor of Statistics at Indian Institute of Management, Lucknow and Professor Vinod Jain for their important inputs.
Compliance with ethical standards
Conflict of interest
All authors declared that they have no conflict of interest.
- 3.Mishra A, Mishra SC, Verma V, Singh HP, Kumar S, Tripathi AM, Patel B, Singh V (2016) In defence of transpalatal, transpalatal-circumaxillary (transpterygopalatine) and transpalatal-circumaxillary-sublabial approaches to lateral extensions of juvenile nasopharyngeal angiofibroma. J Laryngol Otol 130(5):462–473. https://doi.org/10.1017/S0022215116000773 CrossRefGoogle Scholar
- 5.Mishra A, Sachadeva M, Jain A, Mishra Shukla N, Pandey A (2016) Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. Am J Otolaryngol Head Neck Med Surg 37:317–322Google Scholar
- 9.Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J, Fitzpatrick S (1985) Pure brain-derived acidic Fibroblast Growth Factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci USA 82:6409–6413CrossRefGoogle Scholar
- 16.Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS (2001) Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. J Pharmacol Exp Ther 299:1073–1085Google Scholar
- 19.Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, Shapiro RL, Galloway AC, Rifkin DB, Mignatti P (1998) Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol 141(7):1659–1673CrossRefGoogle Scholar
- 25.Jones MK, Itani RM, Wang H, Tomikawa M, Sarfeh IJ, Szabo S, Tarnawski AS (1999) Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury. Am J Physiol 276(6 Pt 1):G1345–G1355Google Scholar
- 27.Yamada S, Yoshimura A (2002) Computer modeling of Ras-MAPK signal transduction pathway. Genome Inform 13:361–362Google Scholar
- 29.Yan D, Ellman MB, Muddasani P, Cs-Szabo G, Im HJ (2012) FGF-2 promotes catabolism via FGFR1-Ras-Raf-MEK1/2-ERK1/2 axis and PKCd pathway in articular chondrocytes. Poster No. 1718 • ORS 2012 Annual MeetingGoogle Scholar
- 30.Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, Zhao K, Levens D (2012) c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151(1):68–79. https://doi.org/10.1016/j.cell.2012.08.033. (PMC 3471363.PMID 23021216) CrossRefGoogle Scholar
- 33.Schick B, Veldung B, Wemmert S, Jung V, Montenarh M, Meese E, Urbschat S (2005) p53 and Her-2/neu in juvenile angiofibromas. Oncol Rep 13:453–457Google Scholar
- 38.Phesse TJ, Myant KB, Cole AM, Ridgway RA, Pearson H, Muncan V, van den Brink GR, Vousden KH, Sears R, Vassilev LT, Clarke AR, Sansom OJ (2014) Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo. Cell Death Differ 21:956–966. https://doi.org/10.1038/cdd.2014.15 CrossRefGoogle Scholar
- 40.Zhang PJ, Weber R, Liang H, Pasha TL, LiVolsi VA (2003) Growth factors and receptors in juvenile nasopharyngeal angiofibroma and nasal polyps. Arch Pathol Lab Med 127:1480–1484Google Scholar